Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Correlated ultrastructural and immunological findings in CD8+ and CD4+ peripheral T-cell lymphomasF Osculati, S Cinti, M Reynès, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1985
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil combined with high-dose folinic acid. An updateD Machover, E Goldschmidt, L Schwarzenberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?]G Mathé, J L Misset, D Machover, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogueG Mathé, P Pontiggia, S Orbach-Arbouys, et al.
Cancer Research|June 15, 1989
Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane(trans-1)oxalatoplatinum(II) in miceN A Boughattas, F Lévi, C Fournier, et al.
Cancer Detection and Prevention|January 1, 1986
Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatmentJ L Misset, G Mathé, G Santelli, et al.
Acta Vitaminologica Et Enzymologica|January 1, 1985
Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatmentJ L Misset, G Mathé, G Santelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in miceN A Boughattas, F Lévi, C Fournier, et al.
Anticancer Research|July 1, 1985
A phase II study of alternating combination chemotherapy in 55 myeloma patients. A comparison with non-alternating combination chemotherapy and treatment with a single cytostaticE Osby, P Reizenstein, G Mathé, et al.
Cancer Letters|December 1, 1984
Experimental protection by a luteinizing hormone-releasing hormone agonist of a bone marrow nitrosourea aplasia. Preliminary observationsG Lemaigre, R Maral, C Bourut, et al.
Pageof 26